A similar discrimination was also seen in the difference between the B-cell ST6Gal1 and monocyte Neu3 levels, which distinguished the ACR improvement group from the non-improvement group, similar to RA patients as a whole as in Figure 1 (Figure 2). This evidence concerns the gene NEU3 and rheumatoid arthritis.